Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.68 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.62 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.62 |
| ▸ | HPGD | P15428 | 4/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | MLYCD | O95822 | 1/20 | 0.61 |
| ▸ | EGFR | P00533 | 1/20 | 0.57 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.51 |
| ▸ | HTR1A | P08908 | 1/20 | 0.51 |
| ▸ | DRD2 | P14416 | 1/20 | 0.51 |
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.50 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4167802 | 0.93 | TP53 (0.59) | TP53HDAC1HDAC6HPGDALDH1A1 | |
| SCHEMBL5166929 | 0.92 | HPGD (0.68) | TP53HDAC1HDAC6HPGDALDH1A1 | |
| SCHEMBL9694832 | 0.89 | MLYCD (0.72) | TP53HDAC1HDAC6HPGDALDH1A1 | |
| SCHEMBL28149291 | 0.89 | ALDH1A1 (0.74) | TP53HDAC1HDAC6HPGDALDH1A1 | |
| SCHEMBL1926269 | 0.89 | HDAC1 (0.73) | TP53HDAC1HDAC6ALDH1A1LIMK1 | |
| SCHEMBL1004032 | 0.88 | HPGD (0.71) | TP53HDAC1HDAC6HPGDALDH1A1 | |
| SCHEMBL9361376 | 0.86 | TP53 (0.60) | TP53HDAC1HDAC6HPGDALDH1A1 | |
| SCHEMBL26314066 | 0.86 | MLYCD (0.64) | TP53HDAC1HDAC6HPGDALDH1A1 | |
| SCHEMBL28497560 | 0.86 | HDAC1 (0.54) | TP53HDAC1HDAC6HPGDALDH1A1 | |
| SCHEMBL19404639 | 0.85 | TP53 (0.51) | TP53HDAC1HDAC6HPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4727996-A1 | METHOD FOR REMOVAL OF ADDITIVES FROM A POLYMERIC MATERIAL | BASF SE (DE) | 2026-04-22 | — | — | EP | claimed |
| WO-2024260970-A1 | METHOD FOR REMOVAL OF ADDITIVES FROM A POLYMERIC MATERIAL | BASF SE (DE) | 2024-12-26 | — | — | WO | claimed |
| CN-101084235-A | 3-deoxyglucosone and skin | DYNAMIS THERAPEUTICS INC (US) | 2007-12-05 | — | — | CN | claimed |
| US-20070225291-A1 | Substituted Pyrazinone Compounds for the Treatment of Inflammation | PFIZER INC. | 2007-09-27 | — | — | US | claimed |
| EP-1678164-B1 | SUBSTITUTED PYRAZINONE COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | PHARMACIA CORP (US) | 2007-04-11 | — | — | EP | claimed |
| CN-1882544-A | Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer s disease | MERCK & CO INC (US) | 2006-12-20 | — | — | CN | claimed |
| EP-1678146-A1 | PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | Pharmacia Corporation (US) | 2006-07-12 | — | — | EP | claimed |
| EP-1678164-A1 | SUBSTITUTED PYRAZINONE COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | Pharmacia Corporation (US) | 2006-07-12 | — | — | EP | claimed |
| CN-1759095-A | N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives | ELAN PHARM INC (US) | 2006-04-12 | — | — | CN | claimed |
| US-20050197338-A1 | Substituted pyrazole urea compounds for the treatment of inflammation | PHARMACIA AND UPJOHN COMPANY LLC | 2005-09-08 | — | — | US | claimed |
| WO-2003047572-A1 | USE OF 1-PHENYL-OXAZOLIDINE-2-ONE COMPOUNDS AS PROTEASE M INHIBITORS | MERCK PATENT GMBH (DE) | 2003-06-12 | — | — | WO | claimed |
| US-20030103915-A1 | Combinations of sunscreens | 3V SIGMA S.P.A. (IT) | 2003-06-05 | — | — | US | claimed |
| EP-1300137-A2 | Combinations of sunscreens | 3V SIGMA S.p.A (IT) | 2003-04-09 | — | — | EP | claimed |
| US-6514485-B1 | Combinations of sunscreens | 3V SIGMA S.P.A. (IT) | 2003-02-04 | — | — | US | claimed |
| EP-0717982-B2 | Process for photostabilizing of dibenzoylmethan derivatives of sunscreen agent, the photostable cosmetic sunscreen compositions and their use | OREAL (FR) | 2001-02-28 | — | — | EP | claimed |
| EP-1027883-A2 | Combinations of sunscreen agents with UV-A and UV-B filtering properties | 3V SIGMA S.p.A (IT) | 2000-08-16 | — | — | EP | claimed |
| EP-0815834-A1 | Photostable cosmetic sunscreen compositions containing a dibenzoylmethan derivative and an amide compound and their use | L'OREAL (FR) | 1998-01-07 | — | — | EP | claimed |
| US-5672337-A | TOPICAL APPLICATION TO SKIN, HAIR | L'OREAL (FR) | 1997-09-30 | — | — | US | claimed |
| EP-0717982-B1 | Process for photostabilizing of dibenzoylmethan derivatives of sunscreen agent, the photostable cosmetic sunscreen compositions and their use | OREAL (FR) | 1997-07-23 | — | — | EP | claimed |
| EP-0717982-A1 | Process for photostabilizing of dibenzoylmethan derivatives of sunscreen agent, the photostable cosmetic sunscreen compositions and their use | L'OREAL (FR) | 1996-06-26 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050197338-A1 | Substituted pyrazole urea compounds for the treatment of inflammation | IL4, ARG2, CASP4 | TP53 711/4885HDAC1 462/4885HDAC6 1341/4885 |
| US-20070225291-A1 | Substituted Pyrazinone Compounds for the Treatment of Inflammation | CNKSR1, IL1RN, CHUK | TP53 1071/4885HDAC1 280/4885HDAC6 925/4885 |
| US-20030103915-A1 | Combinations of sunscreens | ERCC4, ERCC1, ERCC5 | TP53 21/4885HDAC1 1200/4885HDAC6 682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.